Abstract
A significant proportion of methadone patients still are not receiving daily dosing levels that conform to evidence‐based standards of practice, according to data in a new study published in the Journal of Substance Abuse Treatment. The study's lead researcher, who has looked at this topic over a span of nearly 30 years, believes that even within the nation's opioid treatment programs (OTPs), stigma among some professionals toward use of medication‐assisted treatment (MAT) contributes to dosing that may prove too low to encourage treatment retention and reduce illicit drug use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
